Brief: Probi And Sinopharm Enter Strategic Partnership In China

Probi AB

29/03/2021 09:02

March 29 (Reuters) - Sinopharm Group Co Ltd  1099.HK :
    * PROBI AND SINOPHARM ENTER STRATEGIC PARTNERSHIP IN CHINA
    * PROBI(®) AND SINOPHARM, ONE OF CHINA'S LARGEST
PHARMACEUTICAL &
HEALTHCARE COMPANIES ENTER A PARTNERSHIP TO EXPAND OFFERING OF
PREMIUM PROBIOTIC OFFERINGS IN CHINESE MARKET

Source text for Eikon:  ID:nWkr4bhQr1 
Further company coverage:  1099.HK 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))